Phase 3 Endometriosis Trial, Recruiting NCT05726786 Sponsor: Centre Hospitalier Universitaire Vaudois Condition: Endometriosis
Back to Endometriosis

Phase 3 Endometriosis Trial, Recruiting

NCT05726786
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are scheduled to have an open cystectomy (surgical removal of the bladder, for any medical reason)
  • You are 18 years of age or older
  • You are willing and able to give your written consent to take part in the study

Who may not be able to join:

  • You have a known allergy or sensitivity to lactose, fish oil, or soy lecithin
  • You are currently experiencing severe diarrhoea that requires medical treatment
  • You are currently taking any medication that suppresses the immune system
  • You are pregnant or currently breastfeeding
  • You have another serious health condition that affects your immune system, such as severe kidney failure, HIV, lupus, or you have had an organ transplant (confirm with trial site)
  • You have a psychological condition, dementia, or another reason that would make it difficult for you to follow the study procedures
  • You have taken part in another clinical trial involving an experimental drug in the last 30 days, or are currently doing so
  • You have previously been enrolled in this same study
  • You are already using the nutritional supplement being studied outside of this trial
  • You are the investigator running the study, or a close family member, employee, or dependent of theirs
  • Your surgery is planned as an emergency, meaning there are fewer than 7 days between your first assessment and your scheduled operation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +41213142980

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Centre Hospitalier Universitaire Vaudois
Registry
ClinicalTrials.gov
Start date
10 April 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Infectious complication after cystectomy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov